Dubai/Al Ain, June 13, 2019 – Bourn Hall International MENA Ltd., the holding company of the Bourn Hall Fertility Clinics in Dubai and Al Ain and a leading provider of reproductive services in the UAE, today announces the launch of a new electronic Patient Portal.
Katherine Borge, the company’s new Chief Business Officer who spearheaded the launch, explained how the portal will ensure even better privacy, safety and compliance for patients and serve as an electronic medical record system and information resource. “Offering our patients a communication and record-keeping tool that is not only convenient but also safe is an important pillar of our strictly patient-centric approach.”
Through a mobile-friendly electronic platform, the new Patient Portal enables patients to communicate directly with clinicians and staff, review results that are uploaded directly from the lab, and book appointments electronically with automated appointment reminders. Personalized treatment calendars with medication dosage dates and times and educational videos on topics including proper injection technique and procedure preparation will help patients to manage their individual treatment plans.
Hoda-Abou Jamra, Group CEO of BHI, explained how the platform will further enhance the quality of service for the growing number of people in the UAE suffering from fertility issues. “1 in 5 people across all demographics of the UAE have a fertility issue; 50-60% of these are male infertility issues. Females endure most physical parts of the treatment, so it is important to fully understand the emotional turmoil that the patient goes through, to be able to comfort them suitably. Our clinic in Dubai was the first JCI Accredited Fertility Clinic in the Middle East, and so we have always aimed to maintain a very high standard of service and quality.”
Katherine Borge joined Bourn Hall Fertility Clinics in March 2019 with over 6 years in private healthcare in the UAE, most recently as an executive team member of the largest private post-acute care provider in the country. She brings with her a strong international healthcare delivery background and a focus on patient-centric services, with a specialty in healthcare services with emotional, psychological and financial sensitivities for patients and their families. A graduate from Northeastern University, USA, with pre-medical educational background and experience at a Harvard Medical School Affiliate hospital, she was awarded the Rising Star of the Year Award from the Middle East Economic Digest (MEED) in 2018.
The Bourn Hall Fertility Clinic Patient Portal is password protected and can be accessed via http://patients.bournhall-clinic.ae/
About Bourn Hall International MENA Limited
Bourn Hall International MENA Limited operates two world-class branded in vitro fertilization (IVF) reference centres in Dubai and Al Ain, UAE, and is majority-owned by TVM Capital Healthcare. Bourn Hall founders invented IVF in 1978 with the first successful birth of a child, Louise Brown, conceived through an IVF procedure or “test tube baby”. Since then, ‘Bourn Hall’ has become synonymous with IVF and most of what is today the standard treatment protocol for IVF procedures was pioneered and established by Bourn Hall. As the ultimate testament of Bourn Hall’s world-leading expertise, its founder, Professor Robert Edwards, was awarded the Nobel Prize in medicine in 2010 for the invention of IVF.
The Bourn Hall International MENA Limited IVF clinic in Dubai, was the first stand-alone IVF clinic to be JCI accredited in the region. JCI accreditation is considered the gold standard in global health care. JCI consultants are the most skilled and experienced in the industry. The clinic provides several state-of-the-art operating theatres as well as the regions first and largest clean-room laboratory, and hosts a multinational team of Doctors, all assigned specialists in the field of Assisted Reproduction.
© Press Release 2019Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
